143 related articles for article (PubMed ID: 37634258)
1. Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Hagemann IS; Deng W; Zaino RJ; Powell MA; Gunderson Jackson C; Cosgrove C; Mathews C; Pearl ML; Waggoner S; Ghebre R; Lele S; Guntupalli S; Secord AA; Ioffe O; Rasty G; Singh M; Soslow R; Creasman W; Mutch DG
Gynecol Oncol; 2023 Oct; 177():38-45. PubMed ID: 37634258
[TBL] [Abstract][Full Text] [Related]
2. The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women.
Hagemann IS; Deng W; Zaino RJ; Powell MA; Gunderson C; Cosgrove C; Mathews C; Pearl ML; Waggoner S; Ghebre R; Lele S; Guntupalli S; Secord AA; Ioffe O; Park K; Rasty G; Singh M; Soslow R; Creasman W; Mutch DG
Gynecol Oncol; 2021 Mar; 160(3):660-668. PubMed ID: 33423806
[TBL] [Abstract][Full Text] [Related]
3. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
Brinton LA; Felix AS; McMeekin DS; Creasman WT; Sherman ME; Mutch D; Cohn DE; Walker JL; Moore RG; Downs LS; Soslow RA; Zaino R
Gynecol Oncol; 2013 May; 129(2):277-84. PubMed ID: 23485770
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
5. Minor serous and clear cell components adversely affect prognosis in ''mixed-type'' endometrial carcinomas: a clinicopathologic study of 36 stage-I cases.
Quddus MR; Sung CJ; Zhang C; Lawrence WD
Reprod Sci; 2010 Jul; 17(7):673-8. PubMed ID: 20393071
[TBL] [Abstract][Full Text] [Related]
6. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.
Matthews RP; Hutchinson-Colas J; Maiman M; Fruchter RG; Gates EJ; Gibbon D; Remy JC; Sedlis A
Gynecol Oncol; 1997 May; 65(2):206-12. PubMed ID: 9159326
[TBL] [Abstract][Full Text] [Related]
7. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
8. Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Creasman WT; Ali S; Mutch DG; Zaino RJ; Powell MA; Mannel RS; Backes FJ; DiSilvestro PA; Argenta PA; Pearl ML; Lele SB; Guntupalli SR; Waggoner S; Spirtos N; Boggess JF; Edwards RP; Filiaci VL; Miller DS
Gynecol Oncol; 2017 Jun; 145(3):519-525. PubMed ID: 28392124
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?
Ayhan A; Akilli H; Haberal N
Arch Gynecol Obstet; 2019 Jan; 299(1):217-222. PubMed ID: 30315413
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
12. High-stage endometrioid carcinoma of the ovary. Prognostic significance of pure versus mixed histologic types.
Tornos C; Silva EG; Khorana SM; Burke TW
Am J Surg Pathol; 1994 Jul; 18(7):687-93. PubMed ID: 8017563
[TBL] [Abstract][Full Text] [Related]
13. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Brasky TM; Cohn DE; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel C; Boggess JF; Pearl ML; Ioffe OB; Deng W; Miller DS; Brinton LA
Int J Cancer; 2018 Mar; 142(6):1102-1115. PubMed ID: 29063589
[TBL] [Abstract][Full Text] [Related]
14. Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.
Felix AS; Scott McMeekin D; Mutch D; Walker JL; Creasman WT; Cohn DE; Ali S; Moore RG; Downs LS; Ioffe OB; Park KJ; Sherman ME; Brinton LA
Gynecol Oncol; 2015 Oct; 139(1):70-6. PubMed ID: 26341710
[TBL] [Abstract][Full Text] [Related]
15. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Ma X; Cao D; Zhou H; Wang T; Wang J; Zhang Y; Yu M; Cheng N; Peng P; Yang J; Huang H; Shen K
World J Surg Oncol; 2023 Mar; 21(1):106. PubMed ID: 36973753
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
18. Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.
Zaino RJ; Kurman RJ; Brunetto VL; Morrow CP; Bentley RC; Cappellari JO; Bitterman P
Am J Surg Pathol; 1998 Nov; 22(11):1379-85. PubMed ID: 9808130
[TBL] [Abstract][Full Text] [Related]
19. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
Felix AS; Stone RA; Bowser R; Chivukula M; Edwards RP; Weissfeld JL; Linkov F
Int J Gynecol Cancer; 2011 Jul; 21(5):877-84. PubMed ID: 21666484
[TBL] [Abstract][Full Text] [Related]
20. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
Soovares P; Pasanen A; Bützow R; Lassus H
Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
